Health ❯ Obesity ❯ Weight Management

Medications

GLP-1 Drugs GLP-1 Receptor Agonists Tirzepatide Semaglutide Ozempic Zepbound GLP-1 Agonists Orforglipron Insurance Coverage GLP-1 Therapy Semaglutide Benefits Patient Access Long-term Effects Effects of Weight Loss Medications Anti-Obesity Drugs Eli Lilly Weight Loss Medications GLP-1 Delivery Services GLP-1 RAs Clinical Trials Oral Treatments FDA Approval

Large Penn Study Finds GLP‑1 Use Tied to Lower Breast Cancer Rates

Researchers say the observational link points to metabolic and possible direct effects but call for randomized trials before changing care

Shaquille O’Neal Says Zepbound Has Eased His Obstructive Sleep Apnea

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

WeightWatchers Taps Amazon Pharmacy for Faster GLP-1 Access and Delivery

Pilot Study Ties GLP-1 Drugs to Slower Alcohol Absorption and Milder Intoxication

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

Liraglutide Pilot Study Halves Chronic Migraine Days, Paves Way for Randomized Trials